Prognostic significance of dynamic evaluation of C-peptide level in prediction type 1 diabetes mellitus in children
Open Access
- 20 May 2026
- journal article
- research article
- Published by Endocrinology Research Centre in Problems of Endocrinology
- Vol. 72 (2) , 78-85
Abstract
BACKGROUND : Type 1 diabetes mellitus (T1DM) is a chronic progressive autoimmune disease characterized by destruction of pancreatic betta cells leading to insulin deficiency, measured by C-peptide testing. C-peptide secretion has been studied in diagnostic, prognostic and therapeutic aspects in patients with already manifested T1DM. Insulin secretion assessed by the level of C-peptide at the preclinical stage remains under-studied. AIM : The aim of the study was to assess the possibility of predicting the development of T1DM in healthy siblings based on dynamic measurements of C-peptide concentration. MATERIALS AND METHODS : A multicenter prospective longitudinal study involving 532 individuals was conducted. Median follow-up duration was 5.6 years. Group 1 (n=325) included children aged 0–18 years with newly diagnosed T1DM; group 2 (n=201) consisted of healthy brothers and sisters (siblings) who did not develop T1DM until the end of the study; group 3 (n=6) comprised healthy siblings who developed T1DM before the study completion. All participants underwent dynamic testing of blood analysis for C-peptide using solid-phase chemiluminescent immunoassay. RESULTS : In groups 1 and 3, the actual median concentration of baseline C-peptide was below reference values: 0.31 ng/mL [95% CI 0.10–1.39] and 0.56 ng/mL [95% CI 0.32–0.85], respectively. In group 2, it corresponded to the lower limit of reference values: 0.88 ng/mL [95% CI 0.28–2.69]. The observed differences were statistically significant between groups 1 and 2 (χ 2 =168.29, df=1, p < 0.001) and between groups 2 and 3 (χ 2 =4.2292, df=1, p=0.040). Regression modeling revealed a nonlinear positive relationship between C-peptide concentration and age. At any age category, the median initial C-peptide concentration in groups 1 and 3 was lower than that in group 2 above the average level ("intercept") characteristic for the cohort of specific age. The association between C-peptide concentration and time since observation onset was statistically significant (p < 0.05) and bidirectional: over time, concentrations decreased in groups 1 and 3 and increased in group 2. CONCLUSION : Measurement of baseline C-peptide levels followed by dynamic monitoring may serve as an additional screening tool for predicting the risk of T1DM development in healthy siblings.Keywords
This publication has 17 references indexed in Scilit:
- Random C-Peptide and Islet Antibodies at Onset Predict β Cell Function Trajectory and Insulin Dependence in Pediatric DiabetesEndocrine Practice, 2024
- The Predictive Potential of C-Peptide in Differentiating Type 1 Diabetes From Type 2 Diabetes in an Outpatient Population in Abu DhabiClinical Therapeutics, 2024
- Role of Teplizumab, a Humanized Anti-CD3 Monoclonal Antibody, in Managing Newly Diagnosed Type 1 Diabetes: An Updated Systematic Review and Meta-AnalysisEndocrine Practice, 2024
- Comparisons of Metabolic Measures to Predict T1D vs Detect a Preventive Treatment Effect in High-Risk IndividualsThe Journal of Clinical Endocrinology & Metabolism, 2024
- New Frontiers in the Treatment of Type 1 DiabetesCell Metabolism, 2020
- The effect of C-peptide on diabetic nephropathy: A review of molecular mechanismsLife Sciences, 2019
- The remission phase in type 1 diabetes: Changing epidemiology, definitions, and emerging immuno‐metabolic mechanismsDiabetes/Metabolism Research and Reviews, 2019
- Residual beta-cell function in diabetes children followed and diagnosed in the TEDDY study compared to community controlsPediatric Diabetes, 2017
- β Cell death and dysfunction during type 1 diabetes development in at-risk individualsJournal of Clinical Investigation, 2015
- Sequential Changes in Beta-Cell Function in Insulin-Treated Diabetic Patients Assessed by C-Peptide ImmunoreactivityNew England Journal of Medicine, 1973